As far as I know, Evenity doesn't have the same concern for recurrence of sarcoma as Forteo and Tymlos. The black box warning for those drugs about causing bone sarcomas was lifted but the caution for those who have already had a sarcoma is still there. I don't see anything in the insert for Evenity on this: the warning is about heart attack, stroke, cardiovascular events (and the difference between Evenity and placebo looks small).

From the info online it looks safe. It is hard when our endos don't know cancer and our oncologists don't know bones, but you can ask them of course. I often find that pharmacists are good for these questions and even calling Amgen, the manufacturer.